Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Targeting bioenergetics is key to counteracting the drug-tolerant state of biofilm-grown bacteria

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Omics-based tracking of Pseudomonas aeruginosa persistence in "eradicated" cystic fibrosis patients.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Lung clearance index-triggered intervention in children with cystic fibrosis - A randomised pilot study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Gene Loss and Acquisition in Lineages of Pseudomonas aeruginosa Evolving in Cystic Fibrosis Patient Airways

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Despite intensive antibiotic treatment, Pseudomonas aeruginosa often persists in the airways of cystic fibrosis (CF) patients for decades, and can do so without antibiotic resistance development. Using high-throughput screening assays of bacterial survival after treatment with high concentrations of ciprofloxacin, we have determined the prevalence of persisters in a large patient cohort using 460 longitudinal isolates of P. aeruginosa from 39 CF patients. Isolates were classed as high persister variants (Hip) if they regrew following antibiotic treatment in at least 75% of the experimental replicates. Strain genomic data, isolate phenotyping, and patient treatment records were integrated in a lineage-based analysis of persister formation and clinical impact. In total, 19% of the isolates were classified as Hip and Hip emergence increased over lineage colonization time within 22 Hip+ patients. Most Hip+ lineages produced multiple Hip isolates, but few Hip+ lineages were dominated by Hip. While we observed no strong signal of adaptive genetic convergence within Hip isolates, they generally emerged in parallel or following the development of ciprofloxacin resistance and slowed growth. Transient lineages were majority Hip-, while strains that persisted over a clinically diagnosed 'eradication' period were majority Hip+. Patients received indistinguishable treatment regimens before Hip emergence, but Hip+ patients overall were treated significantly more than Hip- patients, signaling repeated treatment failure. When subjected to in vivo-similar antibiotic dosing, a Hip isolate survived better than a non-Hip in a structured biofilm environment. In sum, the Hip phenotype appears to substantially contribute to long-term establishment of a lineage in the CF lung environment. Our results argue against the existence of a single dominant molecular mechanism underlying bacterial antibiotic persistence. We instead show that many routes, both phenotypic and genetic, are available for persister formation and consequent increases in strain fitness and treatment failure in CF airways.

OriginalsprogEngelsk
TidsskriftPLoS pathogens
Vol/bind16
Udgave nummer12
Sider (fra-til)e1009112
ISSN1553-7366
DOI
StatusUdgivet - dec. 2020

ID: 61993229